author_facet Massa, Horace
Nagar, Anindyt M.
Vergados, Athanasios
Dadoukis, Panagiotis
Patra, Sudeshna
Panos, Georgios D.
Massa, Horace
Nagar, Anindyt M.
Vergados, Athanasios
Dadoukis, Panagiotis
Patra, Sudeshna
Panos, Georgios D.
author Massa, Horace
Nagar, Anindyt M.
Vergados, Athanasios
Dadoukis, Panagiotis
Patra, Sudeshna
Panos, Georgios D.
spellingShingle Massa, Horace
Nagar, Anindyt M.
Vergados, Athanasios
Dadoukis, Panagiotis
Patra, Sudeshna
Panos, Georgios D.
Journal of International Medical Research
Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review
Biochemistry (medical)
Cell Biology
Biochemistry
General Medicine
author_sort massa, horace
spelling Massa, Horace Nagar, Anindyt M. Vergados, Athanasios Dadoukis, Panagiotis Patra, Sudeshna Panos, Georgios D. 0300-0605 1473-2300 SAGE Publications Biochemistry (medical) Cell Biology Biochemistry General Medicine http://dx.doi.org/10.1177/0300060518816884 <jats:p>Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy and may lead to severe visual loss. In this review, we describe the pathophysiology of DMO and review current therapeutic options such as macular laser photocoagulation, anti-vascular endothelial growth factor agents, and steroid implants with a focus on the new fluocinolone acetonide implant, ILUVIEN®. The results of the Fluocinolone Acetonide in Diabetic Macular Edema (FAME) studies are also presented together with the results of real-world studies to support the clinical use of ILUVIEN® in achieving efficient resolution of DMO and improving vision and macular anatomy in this challenging group of patients.</jats:p> Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review Journal of International Medical Research
doi_str_mv 10.1177/0300060518816884
facet_avail Online
Free
finc_class_facet Biologie
Chemie und Pharmazie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8wMzAwMDYwNTE4ODE2ODg0
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8wMzAwMDYwNTE4ODE2ODg0
institution DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
imprint SAGE Publications, 2019
imprint_str_mv SAGE Publications, 2019
issn 0300-0605
1473-2300
issn_str_mv 0300-0605
1473-2300
language English
mega_collection SAGE Publications (CrossRef)
match_str massa2019intravitrealfluocinoloneacetonideimplantiluvienrfordiabeticmacularoedemaaliteraturereview
publishDateSort 2019
publisher SAGE Publications
recordtype ai
record_format ai
series Journal of International Medical Research
source_id 49
title Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review
title_unstemmed Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review
title_full Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review
title_fullStr Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review
title_full_unstemmed Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review
title_short Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review
title_sort intravitreal fluocinolone acetonide implant (iluvien®) for diabetic macular oedema: a literature review
topic Biochemistry (medical)
Cell Biology
Biochemistry
General Medicine
url http://dx.doi.org/10.1177/0300060518816884
publishDate 2019
physical 31-43
description <jats:p>Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy and may lead to severe visual loss. In this review, we describe the pathophysiology of DMO and review current therapeutic options such as macular laser photocoagulation, anti-vascular endothelial growth factor agents, and steroid implants with a focus on the new fluocinolone acetonide implant, ILUVIEN®. The results of the Fluocinolone Acetonide in Diabetic Macular Edema (FAME) studies are also presented together with the results of real-world studies to support the clinical use of ILUVIEN® in achieving efficient resolution of DMO and improving vision and macular anatomy in this challenging group of patients.</jats:p>
container_issue 1
container_start_page 31
container_title Journal of International Medical Research
container_volume 47
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792347403736580102
geogr_code not assigned
last_indexed 2024-03-01T17:54:21.745Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Intravitreal+fluocinolone+acetonide+implant+%28ILUVIEN%C2%AE%29+for+diabetic+macular+oedema%3A+a+literature+review&rft.date=2019-01-01&genre=article&issn=1473-2300&volume=47&issue=1&spage=31&epage=43&pages=31-43&jtitle=Journal+of+International+Medical+Research&atitle=Intravitreal+fluocinolone+acetonide+implant+%28ILUVIEN%C2%AE%29+for+diabetic+macular+oedema%3A+a+literature+review&aulast=Panos&aufirst=Georgios+D.&rft_id=info%3Adoi%2F10.1177%2F0300060518816884&rft.language%5B0%5D=eng
SOLR
_version_ 1792347403736580102
author Massa, Horace, Nagar, Anindyt M., Vergados, Athanasios, Dadoukis, Panagiotis, Patra, Sudeshna, Panos, Georgios D.
author_facet Massa, Horace, Nagar, Anindyt M., Vergados, Athanasios, Dadoukis, Panagiotis, Patra, Sudeshna, Panos, Georgios D., Massa, Horace, Nagar, Anindyt M., Vergados, Athanasios, Dadoukis, Panagiotis, Patra, Sudeshna, Panos, Georgios D.
author_sort massa, horace
container_issue 1
container_start_page 31
container_title Journal of International Medical Research
container_volume 47
description <jats:p>Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy and may lead to severe visual loss. In this review, we describe the pathophysiology of DMO and review current therapeutic options such as macular laser photocoagulation, anti-vascular endothelial growth factor agents, and steroid implants with a focus on the new fluocinolone acetonide implant, ILUVIEN®. The results of the Fluocinolone Acetonide in Diabetic Macular Edema (FAME) studies are also presented together with the results of real-world studies to support the clinical use of ILUVIEN® in achieving efficient resolution of DMO and improving vision and macular anatomy in this challenging group of patients.</jats:p>
doi_str_mv 10.1177/0300060518816884
facet_avail Online, Free
finc_class_facet Biologie, Chemie und Pharmazie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8wMzAwMDYwNTE4ODE2ODg0
imprint SAGE Publications, 2019
imprint_str_mv SAGE Publications, 2019
institution DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229
issn 0300-0605, 1473-2300
issn_str_mv 0300-0605, 1473-2300
language English
last_indexed 2024-03-01T17:54:21.745Z
match_str massa2019intravitrealfluocinoloneacetonideimplantiluvienrfordiabeticmacularoedemaaliteraturereview
mega_collection SAGE Publications (CrossRef)
physical 31-43
publishDate 2019
publishDateSort 2019
publisher SAGE Publications
record_format ai
recordtype ai
series Journal of International Medical Research
source_id 49
spelling Massa, Horace Nagar, Anindyt M. Vergados, Athanasios Dadoukis, Panagiotis Patra, Sudeshna Panos, Georgios D. 0300-0605 1473-2300 SAGE Publications Biochemistry (medical) Cell Biology Biochemistry General Medicine http://dx.doi.org/10.1177/0300060518816884 <jats:p>Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy and may lead to severe visual loss. In this review, we describe the pathophysiology of DMO and review current therapeutic options such as macular laser photocoagulation, anti-vascular endothelial growth factor agents, and steroid implants with a focus on the new fluocinolone acetonide implant, ILUVIEN®. The results of the Fluocinolone Acetonide in Diabetic Macular Edema (FAME) studies are also presented together with the results of real-world studies to support the clinical use of ILUVIEN® in achieving efficient resolution of DMO and improving vision and macular anatomy in this challenging group of patients.</jats:p> Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review Journal of International Medical Research
spellingShingle Massa, Horace, Nagar, Anindyt M., Vergados, Athanasios, Dadoukis, Panagiotis, Patra, Sudeshna, Panos, Georgios D., Journal of International Medical Research, Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review, Biochemistry (medical), Cell Biology, Biochemistry, General Medicine
title Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review
title_full Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review
title_fullStr Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review
title_full_unstemmed Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review
title_short Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review
title_sort intravitreal fluocinolone acetonide implant (iluvien®) for diabetic macular oedema: a literature review
title_unstemmed Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review
topic Biochemistry (medical), Cell Biology, Biochemistry, General Medicine
url http://dx.doi.org/10.1177/0300060518816884